Viralytics is a biotechnology company focused on the development and commercialization of oncology immunotherapies to infect and kill cancer cells. Its lead product CAVATAK is a naturally occurring, genetically unaltered virus with activity in a range of cancer types, including melanoma, prostate, lung, and bladder cancers.